← FDA Drug Approvals (Drugs@FDA)
ESOMEPRAZOLE MAGNESIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GRAVITI PHARMS · Approved 2022-06-24
Drug application
- FDA Application #
ANDA216349- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ESOMEPRAZOLE MAGNESIUM
- Generic name
- ESOMEPRAZOLE MAGNESIUM
- Active ingredients
- ESOMEPRAZOLE MAGNESIUM
- Dosage form
- CAPSULE, DELAYED RELEASE
- Route
- ORAL
- Marketing status
- Over-the-counter
- Sponsor
- GRAVITI PHARMS
- Manufacturer
- Rising Pharma Holdings, Inc.
- First approval
- 2022-06-24
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown